SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS?
Sign Up to like & getrecommendations! Published in 2020 at "Herz"
DOI: 10.1007/s00059-020-04925-z
Abstract: Coronavirusdisease2019 (COVID-19) is caused by the single-stranded enveloped RNA virus SARS-CoV-2. It has become a worldwide pandemic since it appeared in Wuhan in December 2019. SARSCoV-2 is theseventhhumancoronavirus, which affects primarily the respiratory tract. Severely… read more here.
Keywords: potential cause; heart; cause cardiac; cov potential ... See more keywords
Immunotherapy for SARS-CoV-2: potential opportunities
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2020.1807933
Abstract: Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus, called Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan, Hubei province of China... read more here.
Keywords: immunotherapy sars; potential opportunities; coronavirus; cov potential ... See more keywords
Characteristics of SARS-CoV-2 and potential pharmacological treatment
Sign Up to like & getrecommendations! Published in 2020 at "Postepy biochemii"
DOI: 10.18388/pb.2020_321
Abstract: In December 2019 in Wuhan, China the first cases of previously unknown, coronaviral infection-induced pneumonia have been reported. The new virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) was named after SARS-CoV due to their… read more here.
Keywords: potential pharmacological; pharmacological treatment; characteristics sars; cov potential ... See more keywords
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
Sign Up to like & getrecommendations! Published in 2020 at "eLife"
DOI: 10.7554/elife.57877
Abstract: We review aspects of the antibody response to SARS-CoV-2, the causative agent of the COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from recovered patients, monoclonal antibodies against the viral S-protein,… read more here.
Keywords: potential therapeutic; passive immunization; antibodies sars; therapeutic passive ... See more keywords